112 related articles for article (PubMed ID: 3536506)
1. Comparative in vitro activity of RU 28965 against Chlamydia trachomatis.
Cevenini R; Sambri V; La Placa M
Eur J Clin Microbiol; 1986 Oct; 5(5):598-600. PubMed ID: 3536506
[No Abstract] [Full Text] [Related]
2. In vitro activity of Ro 15-8074, Ro 19-5247, A-56268, and roxithromycin (RU 28965) against Neisseria gonorrhoeae and Chlamydia trachomatis.
Bowie WR; Shaw CE; Chan DG; Black WA
Antimicrob Agents Chemother; 1987 Mar; 31(3):470-2. PubMed ID: 2953304
[TBL] [Abstract][Full Text] [Related]
3. [Comparative in vitro activity of a new macrolide RU 28965 and of erythromycin against Chlamydia trachomatis].
Dutilh B; de Barbeyrac B; Lafferrière C; Bébéar C
Pathol Biol (Paris); 1986 May; 34(5):445-7. PubMed ID: 3534718
[TBL] [Abstract][Full Text] [Related]
4. [In vitro, activity of a new macrolide (RU 28965) against Chlamydia trachomatis and Ureaplasma urealyticum].
Sambri V; Rumpianesi F; Franchi L; Cevenini R
G Ital Chemioter; 1985; 32(1):175-6. PubMed ID: 3830774
[No Abstract] [Full Text] [Related]
5. In vitro activity of rosaramicin against Chlamydia trachomatis.
Bowie WR
Antimicrob Agents Chemother; 1980 Dec; 18(6):978-9. PubMed ID: 7235684
[TBL] [Abstract][Full Text] [Related]
6. The activity of miokamycin (MOM) against Chlamydia trachomatis and mycoplasmas in vitro.
Ridgway GL; Mumtaz G; Gabriel G; Oriel JD
J Antimicrob Chemother; 1983 Nov; 12(5):511-4. PubMed ID: 6608516
[TBL] [Abstract][Full Text] [Related]
7. Antimicrobial activity of U-70138F (paldimycin), roxithromycin (RU 965), and ofloxacin (ORF 18489) against Chlamydia trachomatis in cell culture.
Stamm WE; Suchland R
Antimicrob Agents Chemother; 1986 Nov; 30(5):806-7. PubMed ID: 3467650
[TBL] [Abstract][Full Text] [Related]
8. In vitro susceptibility of 30 strains of Chlamydia trachomatis to rosamicin.
Smith TF; Washton HE
Antimicrob Agents Chemother; 1978 Sep; 14(3):493-4. PubMed ID: 708027
[TBL] [Abstract][Full Text] [Related]
9. In vitro evaluation of CP-62,993, erythromycin, clindamycin, and tetracycline against Chlamydia trachomatis.
Walsh M; Kappus EW; Quinn TC
Antimicrob Agents Chemother; 1987 May; 31(5):811-2. PubMed ID: 3038010
[TBL] [Abstract][Full Text] [Related]
10. Susceptibility of Chlamydia trachomatis to antibiotics in vitro and in vivo.
Johannisson G; Sernryd A; Lycke E
Sex Transm Dis; 1979; 6(2):50-7. PubMed ID: 494040
[TBL] [Abstract][Full Text] [Related]
11. Comparative in vitro activity of A-56268 (TE-031) against gram-positive and gram-negative bacteria and Chlamydia trachomatis.
Benson C; Segreti J; Kessler H; Hines D; Goodman L; Kaplan R; Trenholme G
Eur J Clin Microbiol; 1987 Apr; 6(2):173-8. PubMed ID: 2954818
[TBL] [Abstract][Full Text] [Related]
12. Enzyme-linked immunosorbent assay for the in-vitro detection of sensitivity of Chlamydia trachomatis to antimicrobial drugs.
Cevenini R; Donati M; Sambri V; Rumpianesi F; La Placa M
J Antimicrob Chemother; 1987 Nov; 20(5):677-84. PubMed ID: 3323161
[TBL] [Abstract][Full Text] [Related]
13. A method for testing the antibiotic susceptibility of Chlamydia trachomatis in a cell culture system.
Ridgway GL; Owen JM; Oriel JD
J Antimicrob Chemother; 1976 Mar; 2(1):71-6. PubMed ID: 931835
[No Abstract] [Full Text] [Related]
14. In-vitro activity of RU 28965, a new macrolide, compared to that of erythromycin.
Rolston KV; LeBlanc B; Ho DH
J Antimicrob Chemother; 1986 Feb; 17(2):161-3. PubMed ID: 3700283
[TBL] [Abstract][Full Text] [Related]
15. [Susceptibility study on urogenital Chlamydia trachomatis to 19 kinds of antibiotics].
Bai H; Dong J; Ning B
Zhonghua Yi Xue Za Zhi; 1995 Jan; 75(1):11-4, 60. PubMed ID: 7600311
[TBL] [Abstract][Full Text] [Related]
16. Commercially available fluorescein-conjugated monoclonal antibody for determining the in vitro activity of antimicrobial agents against Chlamydia trachomatis.
Webberley JM; Matthews RS; Andrews JM; Wise R
Eur J Clin Microbiol; 1987 Oct; 6(5):587-9. PubMed ID: 2449348
[TBL] [Abstract][Full Text] [Related]
17. A comparison of the in-vitro activity of antimicrobials against Chlamydia trachomatis examined by Giemsa and a fluorescent antibody stain.
How SJ; Hobson D; Hart CA; Quayle E
J Antimicrob Chemother; 1985 Apr; 15(4):399-404. PubMed ID: 3891709
[TBL] [Abstract][Full Text] [Related]
18. In-vitro activity of 3-azinomethyl-rifamycin (SPA-S-565) against Chlamydia trachomatis.
Zanetti S; Usai D; Nonis A; Fadda G
J Antimicrob Chemother; 1996 Feb; 37(2):357-9. PubMed ID: 8707747
[TBL] [Abstract][Full Text] [Related]
19. In-vitro activity of dirithromycin against Chlamydia pneumoniae.
Roblin PM; Kutlin A; Sokolovskaya N; Hammerschlag MR
J Antimicrob Chemother; 1997 May; 39(5):647-9. PubMed ID: 9184366
[TBL] [Abstract][Full Text] [Related]
20. In vitro susceptibility of recent clinical isolates of Chlamydia trachomatis to macrolides and tetracyclines.
Samra Z; Rosenberg S; Soffer Y; Dan M
Diagn Microbiol Infect Dis; 2001 Mar; 39(3):177-9. PubMed ID: 11337185
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
